Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea
· Delayed Price · Currency is KRW 2,965.00
-5.00 (-0.17%)
At close: Dec 5, 2025
Precision Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 19,737 | 19,134 | 20,391 | 20,458 | 15,887 | 8,685 | Upgrade
|
| Other Revenue | - | -0 | - | - | -0 | - | Upgrade
|
| Revenue | 19,737 | 19,134 | 20,391 | 20,458 | 15,887 | 8,685 | Upgrade
|
| Revenue Growth (YoY) | 8.35% | -6.17% | -0.33% | 28.77% | 82.93% | 39.97% | Upgrade
|
| Cost of Revenue | 13,255 | 12,952 | 12,705 | 13,703 | 11,282 | 3,918 | Upgrade
|
| Gross Profit | 6,482 | 6,182 | 7,686 | 6,755 | 4,605 | 4,767 | Upgrade
|
| Selling, General & Admin | 7,004 | 6,406 | 7,288 | 7,437 | 6,303 | 3,783 | Upgrade
|
| Research & Development | 2,829 | 3,586 | 3,196 | 2,611 | 1,958 | 2,045 | Upgrade
|
| Amortization of Goodwill & Intangibles | 548.63 | 548.63 | 547.69 | 50.22 | 1.85 | 3.05 | Upgrade
|
| Other Operating Expenses | 405.52 | 363.88 | 249.05 | 231.68 | 243.58 | 230.47 | Upgrade
|
| Operating Expenses | 11,381 | 11,549 | 12,496 | 11,255 | 8,874 | 6,485 | Upgrade
|
| Operating Income | -4,899 | -5,366 | -4,811 | -4,500 | -4,269 | -1,719 | Upgrade
|
| Interest Expense | -2,131 | -1,991 | -1,230 | -816.95 | -162.1 | -23.57 | Upgrade
|
| Interest & Investment Income | 95.3 | 164.95 | 188.19 | 187.26 | 70.52 | 71.82 | Upgrade
|
| Currency Exchange Gain (Loss) | 82.45 | 577.46 | 196.85 | 254.17 | 285.95 | -142.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -753.83 | -709.87 | -172.23 | -2,273 | -254.15 | -2,997 | Upgrade
|
| EBT Excluding Unusual Items | -7,605 | -7,324 | -5,827 | -7,148 | -4,329 | -4,810 | Upgrade
|
| Gain (Loss) on Sale of Investments | 8.36 | 33.36 | 90.06 | 137.79 | 48.66 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -16.05 | 3.01 | - | 5.27 | 0.03 | -142.71 | Upgrade
|
| Other Unusual Items | 257.29 | 319.15 | 354.95 | - | - | - | Upgrade
|
| Pretax Income | -7,356 | -6,969 | -5,382 | -7,005 | -4,281 | -4,953 | Upgrade
|
| Income Tax Expense | 520.3 | 336.5 | -892.03 | -199.36 | -128.31 | 0.3 | Upgrade
|
| Net Income | -7,876 | -7,305 | -4,490 | -6,806 | -4,152 | -4,953 | Upgrade
|
| Net Income to Common | -7,876 | -7,305 | -4,490 | -6,806 | -4,152 | -4,953 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 11 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 11 | 9 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.09% | 0.67% | 2.10% | 25.37% | 24.75% | Upgrade
|
| EPS (Basic) | -677.98 | -628.96 | -386.98 | -590.47 | -367.80 | -550.04 | Upgrade
|
| EPS (Diluted) | -678.02 | -629.00 | -387.00 | -590.47 | -368.00 | -550.04 | Upgrade
|
| Free Cash Flow | -1,615 | -1,509 | -9,006 | -13,719 | -13,726 | -6,950 | Upgrade
|
| Free Cash Flow Per Share | -139.05 | -129.92 | -776.13 | -1190.18 | -1215.81 | -771.85 | Upgrade
|
| Gross Margin | 32.84% | 32.31% | 37.69% | 33.02% | 28.98% | 54.89% | Upgrade
|
| Operating Margin | -24.82% | -28.04% | -23.59% | -22.00% | -26.87% | -19.79% | Upgrade
|
| Profit Margin | -39.91% | -38.18% | -22.02% | -33.27% | -26.14% | -57.03% | Upgrade
|
| Free Cash Flow Margin | -8.18% | -7.89% | -44.17% | -67.06% | -86.40% | -80.03% | Upgrade
|
| EBITDA | -922.54 | -1,777 | -1,665 | -2,218 | -3,091 | -948.01 | Upgrade
|
| EBITDA Margin | -4.67% | -9.29% | -8.17% | -10.84% | -19.45% | -10.91% | Upgrade
|
| D&A For EBITDA | 3,976 | 3,590 | 3,145 | 2,282 | 1,179 | 770.51 | Upgrade
|
| EBIT | -4,899 | -5,366 | -4,811 | -4,500 | -4,269 | -1,719 | Upgrade
|
| EBIT Margin | -24.82% | -28.04% | -23.59% | -22.00% | -26.87% | -19.79% | Upgrade
|
| Advertising Expenses | - | 114.04 | 200 | 76.59 | 108.79 | 30.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.